Alexandre Pariente

13.2k total citations · 4 hit papers
296 papers, 8.1k citations indexed

About

Alexandre Pariente is a scholar working on Toxicology, Pharmacology and Epidemiology. According to data from OpenAlex, Alexandre Pariente has authored 296 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Toxicology, 44 papers in Pharmacology and 44 papers in Epidemiology. Recurrent topics in Alexandre Pariente's work include Pharmacovigilance and Adverse Drug Reactions (69 papers), Pharmaceutical Practices and Patient Outcomes (37 papers) and Drug-Induced Adverse Reactions (23 papers). Alexandre Pariente is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (69 papers), Pharmaceutical Practices and Patient Outcomes (37 papers) and Drug-Induced Adverse Reactions (23 papers). Alexandre Pariente collaborates with scholars based in France, Italy and United States. Alexandre Pariente's co-authors include Nicholas Moore, Bernard Bégaud, Annie Fourrier‐Réglat, Francesco Salvo, Julien Bezin, Sophie Billioti de Gage, Marie Tournier, Tobias Kurth, R. Lassalle and Patrick Blin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Alexandre Pariente

265 papers receiving 7.9k citations

Hit Papers

Cardiovascular toxicities... 2014 2026 2018 2022 2018 2017 2014 2022 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
    2018 836 citations Alexandre Pariente et al. profile →
  2. The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology
    2017 398 citations Julien Bezin, R. Lassalle et al. profile →
  3. Benzodiazepine use and risk of Alzheimer's disease: case-control study
    2014 380 citations Hélène Verdoux, Marie Tournier et al. profile →
  4. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
    2022 184 citations Julien Bezin, Amandine Gouverneur et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Alexandre Pariente 1.2k 1.2k 1.1k 1.0k 1.0k 296 8.1k
Ron M. C. Herings 1.2k 0.9× 569 0.5× 1.2k 1.0× 803 0.8× 741 0.7× 247 8.4k
C. A. Naranjo 782 0.6× 1.3k 1.2× 747 0.7× 1.4k 1.3× 1.2k 1.2× 42 9.4k
U. Busto 806 0.7× 1.4k 1.2× 744 0.6× 1.3k 1.3× 1.0k 1.0× 34 9.0k
Anton Pottegård 923 0.7× 323 0.3× 1.5k 1.3× 1.1k 1.1× 1.3k 1.3× 385 10.0k
D J Greenblatt 862 0.7× 1.3k 1.2× 887 0.8× 1.4k 1.3× 1.0k 1.0× 46 9.5k
Gianluca Trifirò 356 0.3× 1.4k 1.2× 741 0.6× 795 0.8× 683 0.7× 270 7.0k
Jean‐Louis Montastruc 266 0.2× 1.3k 1.1× 1.1k 0.9× 1.1k 1.0× 884 0.9× 458 10.5k
Maryse Lapeyre‐Mestre 299 0.2× 1.5k 1.3× 730 0.6× 1.2k 1.2× 1.1k 1.1× 435 9.0k
Annalisa Capuano 821 0.7× 566 0.5× 635 0.6× 362 0.3× 532 0.5× 266 5.8k
David W. Bates 393 0.3× 598 0.5× 1.1k 1.0× 572 0.5× 1.4k 1.4× 98 10.3k

Countries citing papers authored by Alexandre Pariente

Since Specialization
Citations

This map shows the geographic impact of Alexandre Pariente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Pariente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Pariente more than expected).

Fields of papers citing papers by Alexandre Pariente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Pariente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Pariente. The network helps show where Alexandre Pariente may publish in the future.

Co-authorship network of co-authors of Alexandre Pariente

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Pariente. A scholar is included among the top collaborators of Alexandre Pariente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Pariente. Alexandre Pariente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jonville‐Béra, A.‐P., et al.. (2025). The safety profile of fluoroquinolones. Infectious Diseases Now. 55(4). 105064–105064.
2.
Cochat, Pierre, et al.. (2024). Can requests for real-world evidence by the French HTA body be planned? An exhaustive retrospective case–control study of medicinal products appraisals from 2016 to 2021. International Journal of Technology Assessment in Health Care. 40(1). e33–e33. 3 indexed citations
3.
4.
Constans, J., Carine Boulon, Caroline Caradu, et al.. (2023). Effects of iloprost in patients with critical limb ischemia: Results of a cohort study from the COPART registry. JMV-Journal de Médecine Vasculaire. 48(5-6). 163–173.
5.
Maumus‐Robert, Sandy, et al.. (2023). Trajectories of Benzodiazepine Use among Older Adults from a Concordance-with-Guidelines Perspective: A Nationwide Cohort Study. Drugs & Aging. 40(10). 919–931. 3 indexed citations
6.
Valnet‐Rabier, Marie‐Blanche, Sophie Gautier, Joëlle Micallef, et al.. (2023). Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran). Therapies. 78(5). 499–507. 7 indexed citations
7.
Mathieu, Clément, Élodie Pambrun, Anne Bénard‐Laribière, et al.. (2022). Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study. European Journal of Epidemiology. 37(10). 1049–1059. 15 indexed citations
8.
Gouverneur, Amandine, Jérôme Avouac, Clément Prati, et al.. (2022). JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study. European Journal of Clinical Pharmacology. 78(12). 1981–1990. 19 indexed citations
9.
Tournier, Marie, Élodie Pambrun, Sandy Maumus‐Robert, Alexandre Pariente, & Hélène Verdoux. (2021). The risk of dementia in patients using psychotropic drugs: Antidepressants, mood stabilizers or antipsychotics. Acta Psychiatrica Scandinavica. 145(1). 56–66. 11 indexed citations
10.
Maumus‐Robert, Sandy, et al.. (2021). Chronic polypharmacy at all age: A population‐based drug utilization study. Fundamental and Clinical Pharmacology. 36(2). 405–413. 6 indexed citations
11.
Largeau, Bérenger, et al.. (2021). Specific features of amoxicillin‐associated Drug Reaction with Eosinophilia and Systemic Symptoms syndrome: a nationwide study. Journal of the European Academy of Dermatology and Venereology. 35(12). 2415–2420. 5 indexed citations
12.
Jacqmin‐Gadda, Hélène, et al.. (2020). Impact of benzodiazepine consumption reduction on future burden of dementia. Scientific Reports. 10(1). 14666–14666. 7 indexed citations
13.
Maumus‐Robert, Sandy, Stéphanie Debette, Xavier Bérard, et al.. (2020). Risk of Intracranial Aneurysm and Dissection and Fluoroquinolone Use. Stroke. 51(3). 994–997. 15 indexed citations
14.
15.
Bellet, Florelle, et al.. (2019). Pharmacology and social media: Potentials and biases of web forums for drug mention analysis—case study of France. Health Informatics Journal. 26(2). 1253–1272. 5 indexed citations
16.
Bénard‐Laribière, Anne, Alexandre Pariente, Élodie Pambrun, et al.. (2017). Prevalence and prescription patterns of oral glucocorticoids in adults: a retrospective cross-sectional and cohort analysis in France. BMJ Open. 7(7). e015905–e015905. 70 indexed citations
17.
Blin, Patrick, R. Lassalle, C. Dureau‐Pournin, et al.. (2012). Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database. Diabetologia. 55(3). 644–653. 70 indexed citations
18.
Renou, Christophe, et al.. (2009). How to detect and diagnose an autochthonous hepatitis E. Gastroentérologie Clinique et Biologique. 33. 2 indexed citations
19.
Cottet, Vanessa, Alexandre Pariente, Bernard Nalet, et al.. (2007). Colonoscopic Screening of First-Degree Relatives of Patients With Large Adenomas: Increased Risk of Colorectal Tumors. Gastroenterology. 133(4). 1086–1092. 66 indexed citations
20.
Pariente, Alexandre. (2003). Hépatites auto-immunes : prise en charge thérapeutique. Gastroentérologie Clinique et Biologique. 27(5). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ron M. C. Herings Breakdown of academic impact, for papers by C. A. Naranjo Breakdown of academic impact, for papers by U. Busto Breakdown of academic impact, for papers by Anton Pottegård Breakdown of academic impact, for papers by D J Greenblatt Breakdown of academic impact, for papers by Gianluca Trifirò Breakdown of academic impact, for papers by Jean‐Louis Montastruc Breakdown of academic impact, for papers by Maryse Lapeyre‐Mestre Breakdown of academic impact, for papers by Annalisa Capuano Breakdown of academic impact, for papers by David W. Bates
Rankless by CCL
2026